SEPN · Categories · Form 4

SEPN - SEC Form 4 insider transactions

Septerna Inc. (SEPN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SEPN

• 9d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - Septerna, Inc. (0001984086) (Issuer)
• 53d
  Chief People Officer Shaikhly Samira exercised 70,453 shares at a strike of $1.84 and sold $1,979,838 worth of shares (70,453 units at $28.10) (SEC Form 4)

  4 - Septerna, Inc. (0001984086) (Issuer)
• 65d
  President and COO Bhatt Elizabeth exercised 4,000 shares at a strike of $6.81 and sold $115,860 worth of shares (4,000 units at $28.97) (SEC Form 4)

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by SVP, Drug Discovery Long Daniel D.

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by SVP, Biological Sciences Klein Uwe

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by Chief People Officer Shaikhly Samira

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by Chief Financial Officer Labrucherie Gil M

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by Chief Medical Officer Kim Jae B.

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by President and COO Bhatt Elizabeth

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by Chief Executive Officer Finer Jeffrey

  4 - Septerna, Inc. (0001984086) (Issuer)
• 75d
  SEC Form 4 filed by Chief Legal Officer Wilson Mark Andrew

  4 - Septerna, Inc. (0001984086) (Issuer)
• 164d
  SVP, Drug Discovery Long Daniel D. sold $63,223 worth of shares (3,501 units at $18.06), decreasing direct ownership by 4% to 92,911 units (SEC Form 4)

  4 - Septerna, Inc. (0001984086) (Issuer)
• 209d
  SEC Form 4 filed by Director Gottesdiener Keith Michael

  4 - Septerna, Inc. (0001984086) (Issuer)
• 250d
  SVP, Biological Sciences Klein Uwe exercised 23,008 shares at a strike of $4.10 (SEC Form 4)

  4 - Septerna, Inc. (0001984086) (Issuer)
• 258d
  SEC Form 4 filed by Chief People Officer Shaikhly Samira

  4 - Septerna, Inc. (0001984086) (Issuer)
• 258d
  SEC Form 4 filed by President and COO Bhatt Elizabeth

  4 - Septerna, Inc. (0001984086) (Issuer)
• 258d
  SEC Form 4 filed by Chief Medical Officer Kim Jae B.

  4 - Septerna, Inc. (0001984086) (Issuer)
• 258d
  SEC Form 4 filed by Chief Financial Officer Labrucherie Gil M

  4 - Septerna, Inc. (0001984086) (Issuer)
• 258d
  SEC Form 4 filed by Chief Executive Officer Finer Jeffrey

  4 - Septerna, Inc. (0001984086) (Issuer)
• 258d
  SEC Form 4 filed by SVP, Drug Discovery Long Daniel D.

  4 - Septerna, Inc. (0001984086) (Issuer)
• 258d
  SEC Form 4 filed by SVP, Biological Sciences Klein Uwe

  4 - Septerna, Inc. (0001984086) (Issuer)
• 310d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Septerna, Inc. (0001984086) (Issuer)
• 310d
  SEC Form 4 filed by Director Sharp Shalini

  4 - Septerna, Inc. (0001984086) (Issuer)
• 310d
  SEC Form 4 filed by Director Tong Jeffrey K

  4 - Septerna, Inc. (0001984086) (Issuer)
• 310d
  SEC Form 4 filed by Director Coulie Bernard

  4 - Septerna, Inc. (0001984086) (Issuer)
• 310d
  SEC Form 4 filed by Director Simson Jake

  4 - Septerna, Inc. (0001984086) (Issuer)
• 310d
  SEC Form 4 filed by Director Bassan Abraham

  4 - Septerna, Inc. (0001984086) (Issuer)
• 310d
  SEC Form 4 filed by Director Ezekowitz Alan

  4 - Septerna, Inc. (0001984086) (Issuer)
• 387d
  CEO and President Finer Jeffrey exercised 55,000 shares at a strike of $2.76, increasing direct ownership by 7% to 826,907 units (SEC Form 4)

  4 - Septerna, Inc. (0001984086) (Issuer)
• 443d
  SEC Form 4 filed by Chief Financial Officer Labrucherie Gil M

  4 - Septerna, Inc. (0001984086) (Issuer)

Other SEPN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends